Skip to main content

Ken Garber, Sherri Chasin Calvo, Ken Howard, Steve Castillo

Premium

After persistent calls to Celera for this month’s cover story, “Hooked on Speed,” p. 22, Ken Garber says he finally got an appointment for a phone interview with Craig Venter. Venter stood him up, but Garber says he cleaned his entire apartment while waiting for the call. Garber is a freelance science writer in Ann Arbor, Mich., who has covered biology stories for Technology Review, Science, and other magazines.

Sherri Chasin Calvo, “Model Org,” p. 21, covers genomics from her home, conveniently located near Rockville/Bethesda. She is also the “In the Field” columnist for The Alchemist magazine on ChemWeb.com, where she says she can indulge some of her other interests, including archaeology and astrophysics. As a freelance science writer, Calvo says she is delighted to have found the perfect career for the perpetual student.

“The world according to Win is a strange and beautiful place, bodily fluids and all,” reports Ken Howard, “World Win,” p. 36. In addition to finding out Win Hide’s vision for the future of bioinformatics software and how South African science fits into the puzzle, Howard learned to what level Hide will go not only for his science but also for a quick snack. Howard, a freelance science writer who recently wrote about bioinformatics for Scientific American, is based in New York City.

Steve Castillo, who shot the photos of George Rathmann and the Hyseq team for this issue, is a Palo Alto-based photographer who says he “strives to capture the moment.” Says Castillo, “Photographing companies like Hyseq is exciting because of the history-making technologies they are pursuing and the competitive nature of the business.” He has also shot photos for Hewlett-Packard, Stanford University, and Intel. Castillo covered ProtoGene for the October issue of GT.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.